Skip to main content

Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle

Buy Article:

$50.00 plus tax (Refund Policy)


To understand changes in cyclic nucleotide metabolism in muscle disease states, the expression of phosphodiesterase (PDE) isozymes in normal mouse leg muscle was examined. Four subcellular fractions were generated by differential centrifugation at 10 000 × g and 100 000 × g. cAMP PDE activity was found predominately in the soluble fractions, while cGMP PDE activity was more evenly distributed amongst soluble and particulate fractions. Pharmacological inhibitors demonstrate that PDE4 represents the major cAMP hydrolyzing activity and PDE2 represents the major cGMP hydrolyzing activity in mouse leg muscle. PDE1 is expressed at low levels, while PDE3 and PDE5 are intermediate. Between 20 and 40% of total PDE activity remained in the presence of inhibitors for PDE1–PDE5, indicating that other PDE families contribute to the total PDE pool. Reverse-transcription PCR with family-specific primers showed expression of mRNA for PDE7–PDE9, supporting this conclusion. Total PDE activity was found to be elevated in tissue extracts from a mouse model of Duchenne's muscular dystrophy.Key words: cyclic nucleotide, phosphodiesterase, skeletal muscle, pharmacological inhibitors, muscular dystrophy.

Pour comprendre les modifications du métabolisme des nucléotides cycliques dans les maladies musculaires, on a examiné l'expression des isoenzymes de la phosphodiestérase (PDE) dans le muscle jambier normal de souris. On a produit quatre fractions subcellulaires par centrifugation différentielle à 10 000 × g et 100 000 × g. L'activité PDE de l'AMPc a été prédominante dans les fractions solubles alors que celle du GMPc a été répartie de manière plus uniforme entre les fractions solubles et particulaires. Les inhibiteurs pharmacologiques démontrent que la PDE4 représente l'activité d'hydrolyse majeure de l'AMPc et que la PDE2 représente celle du GMPc dans le muscle jambier de souris. La PDE1 est faiblement exprimée alors que la PDE3 et la PDE5 le sont moyennement. Entre 20–40  % de l'activité PDE totale subsistent en présence d'inhibiteurs de la PDE1–PDE5, ce qui indique que d'autres familles de PDE participent au pool total de PDE. La RT–PCR avec des amorces spécifiques des familles a montré l'expression d'un ARNm pour la PDE7–PDE9, confortant cette conclusion. L'activité PDE totale s'est révélée élevée dans les extraits tissulaires d'un modèle murin de dystrophie musculaire de Duchenne.Mots clés : nucléotide cyclique, phosphodiestérase, muscle squelettique, inhibiteurs pharmacologiques, dystrophie musculaire.[Traduit par la Rédaction]

Keywords: cyclic nucleotide; dystrophie musculaire; inhibiteurs pharmacologiques; muscle squelettique; muscular dystrophy; nucléotide cyclique; pharmacological inhibitors; phosphodiesterase; phosphodiestérase; skeletal muscle

Document Type: Research Article

Publication date: December 1, 2002

More about this publication?
  • Published since 1929, this monthly journal reports current research in all aspects of physiology, nutrition, pharmacology, and toxicology, contributed by recognized experts and scientists. It publishes symposium reviews and award lectures and occasionally dedicates entire issues or portions of issues to subjects of special interest to its international readership.
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Terms & Conditions
  • Sample Issue
  • Reprints & Permissions
  • Ingenta Connect is not responsible for the content or availability of external websites

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more